If this page doesn't display properly in your email, Click here

	February 1, 2008 Meeting on Key Issues in TB Drug Development ...Read Full Article CDC Survey Shows Less Effective Flu Medications Still Used ...Read Full Article EIN: Decolonize MRSA Patients or Not? ...Read Full Article Health Alerts, Drug Approvals, Recalls, Adverse Events ...Read Full Article In the IDSA Journals ...Read Full Article Multidrug-resistant Staph Reported among MSM ...Read Full Article CMS Requires NPI on Claims Starting March 1 ...Read Full Article Europe Reports High Percentage of Oseltamivir-resistant Influenza Virus ...Read Full Article IDSA Policy & Advocacy Update IDSA Opposes Anti-Thimerosal Legislation ...Read Full Article Welcome, New IDSA Members! ...Read Full Article Meeting on Key Issues in TB Drug Development CDC Survey Shows Less Effective Flu Medications Still Used EIN: Decolonize MRSA Patients or Not? Health Alerts, Drug Approvals, Recalls, Adverse Events In the IDSA Journals Multidrug-resistant Staph Reported among MSM CMS Requires NPI on Claims Starting March 1 Europe Reports High Percentage of Oseltamivir-resistant Influenza Virus IDSA Policy & Advocacy Update Welcome, New IDSA Members!		Search Back Issues Forward this Issue Print-Friendly Version Unsubscribe

© Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

To ensure delivery of IDSA News please add idsanews@idsociety.org to your email address book or Safe Sender List. If you are still having
problems receiving our communications, see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm